SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES
To date, cancer diseases are one of the leading causes of mortality and morbidity in the world. Recent advances in understanding the molecular genetic mechanisms of oncogenesis and anti-cancer immune responses open new opportunities for the development of novel effective therapeutic strategies again...
Main Authors: | T. S. Nepomnyashchikh, E. V. Gavrilova, R. A. Maksyutov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2019-05-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/1580 |
Similar Items
-
Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy
by: Colin H. Quinn, et al.
Published: (2022-02-01) -
In Situ Cancer Vaccination and Immunovirotherapy Using Oncolytic HSV
by: Nusrat Jahan, et al.
Published: (2021-08-01) -
To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses
by: Kevin A. Cassady, et al.
Published: (2016-02-01) -
Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors
by: S. Feola, et al.
Published: (2018-08-01) -
Oncolytic Vaccinia Virus in Lung Cancer Vaccines
by: Cao-Sang Truong, et al.
Published: (2022-02-01)